We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » RISKS FROM OFF-LABEL PROMOTIONS GROWING, EXPERTS SAY
RISKS FROM OFF-LABEL PROMOTIONS GROWING, EXPERTS SAY
January 15, 2004
Off-label promotion, long a target of FDA enforcement activities under the Food, Drug and Cosmetic Act, has been garnering increased attention as a potential violation of the False Claims Act — with far greater financial consequences — according to healthcare compliance experts.